Efficacy of Submicron Dispersible Free Phytosterols on Non-Alcoholic Fatty Liver Disease: A Pilot Study

Background: No pharmacological treatment is yet approved for non-alcoholic fatty liver disease (NAFLD). Plant sterols have shown healthy properties beyond lowering LDL-cholesterol, including lowering triglycerides and lipoprotein plasma levels. Despite pre-clinical data suggesting their involvement...

Full description

Bibliographic Details
Main Authors: María C. Brañes, Raimundo Gillet, Rodrigo Valenzuela
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/3/979
_version_ 1797624072506441728
author María C. Brañes
Raimundo Gillet
Rodrigo Valenzuela
author_facet María C. Brañes
Raimundo Gillet
Rodrigo Valenzuela
author_sort María C. Brañes
collection DOAJ
description Background: No pharmacological treatment is yet approved for non-alcoholic fatty liver disease (NAFLD). Plant sterols have shown healthy properties beyond lowering LDL-cholesterol, including lowering triglycerides and lipoprotein plasma levels. Despite pre-clinical data suggesting their involvement in liver fat control, no clinical study has yet been successful. Aims: Testing a sub-micron, free, phytosterol dispersion efficacy on NAFLD. Methods: A prospective, uncontrolled pilot study was carried out on 26 patients with ≥17.4% liver steatosis quantified by magnetic resonance imaging. Subjects consumed daily a sub-micron dispersion providing 2 g of phytosterols. Liver fat, plasma lipids, lipoproteins, liver enzymes, glycemia, insulinemia, phytosterols, liposoluble vitamins and C-reactive protein were assessed at baseline and after one year of treatment. Results: Liver steatosis relative change was −19%, and 27% of patients reduced liver fat by more than 30%. Statistically and clinically significant improvements in plasma triglycerides, HDL-C, VLDL and HDL particle number and C-reactive protein were obtained, despite the rise of aspartate aminotransferase, glycemia and insulinemia. Though phytosterol plasma levels were raised by >30%, no adverse effects were presented, and even vitamin D increased by 23%. Conclusions: Our results are the first evidence in humans of the efficacy of submicron dispersible phytosterols for the treatment of liver steatosis, dyslipidemia and inflammatory status in NAFLD.
first_indexed 2024-03-11T09:38:09Z
format Article
id doaj.art-9b9c7ed3159e4036b2900dc5c791bb4e
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-11T09:38:09Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-9b9c7ed3159e4036b2900dc5c791bb4e2023-11-16T17:09:58ZengMDPI AGJournal of Clinical Medicine2077-03832023-01-0112397910.3390/jcm12030979Efficacy of Submicron Dispersible Free Phytosterols on Non-Alcoholic Fatty Liver Disease: A Pilot StudyMaría C. Brañes0Raimundo Gillet1Rodrigo Valenzuela2Naturalis Research Consortium, Santiago 8700548, ChileNaturalis Research Consortium, Santiago 8700548, ChileDepartment of Nutrition, Faculty of Medicine, University of Chile, Santiago 8380000, ChileBackground: No pharmacological treatment is yet approved for non-alcoholic fatty liver disease (NAFLD). Plant sterols have shown healthy properties beyond lowering LDL-cholesterol, including lowering triglycerides and lipoprotein plasma levels. Despite pre-clinical data suggesting their involvement in liver fat control, no clinical study has yet been successful. Aims: Testing a sub-micron, free, phytosterol dispersion efficacy on NAFLD. Methods: A prospective, uncontrolled pilot study was carried out on 26 patients with ≥17.4% liver steatosis quantified by magnetic resonance imaging. Subjects consumed daily a sub-micron dispersion providing 2 g of phytosterols. Liver fat, plasma lipids, lipoproteins, liver enzymes, glycemia, insulinemia, phytosterols, liposoluble vitamins and C-reactive protein were assessed at baseline and after one year of treatment. Results: Liver steatosis relative change was −19%, and 27% of patients reduced liver fat by more than 30%. Statistically and clinically significant improvements in plasma triglycerides, HDL-C, VLDL and HDL particle number and C-reactive protein were obtained, despite the rise of aspartate aminotransferase, glycemia and insulinemia. Though phytosterol plasma levels were raised by >30%, no adverse effects were presented, and even vitamin D increased by 23%. Conclusions: Our results are the first evidence in humans of the efficacy of submicron dispersible phytosterols for the treatment of liver steatosis, dyslipidemia and inflammatory status in NAFLD.https://www.mdpi.com/2077-0383/12/3/979liver steatosisplant sterolswater-dispersible phytosterolsmetabolic parameters
spellingShingle María C. Brañes
Raimundo Gillet
Rodrigo Valenzuela
Efficacy of Submicron Dispersible Free Phytosterols on Non-Alcoholic Fatty Liver Disease: A Pilot Study
Journal of Clinical Medicine
liver steatosis
plant sterols
water-dispersible phytosterols
metabolic parameters
title Efficacy of Submicron Dispersible Free Phytosterols on Non-Alcoholic Fatty Liver Disease: A Pilot Study
title_full Efficacy of Submicron Dispersible Free Phytosterols on Non-Alcoholic Fatty Liver Disease: A Pilot Study
title_fullStr Efficacy of Submicron Dispersible Free Phytosterols on Non-Alcoholic Fatty Liver Disease: A Pilot Study
title_full_unstemmed Efficacy of Submicron Dispersible Free Phytosterols on Non-Alcoholic Fatty Liver Disease: A Pilot Study
title_short Efficacy of Submicron Dispersible Free Phytosterols on Non-Alcoholic Fatty Liver Disease: A Pilot Study
title_sort efficacy of submicron dispersible free phytosterols on non alcoholic fatty liver disease a pilot study
topic liver steatosis
plant sterols
water-dispersible phytosterols
metabolic parameters
url https://www.mdpi.com/2077-0383/12/3/979
work_keys_str_mv AT mariacbranes efficacyofsubmicrondispersiblefreephytosterolsonnonalcoholicfattyliverdiseaseapilotstudy
AT raimundogillet efficacyofsubmicrondispersiblefreephytosterolsonnonalcoholicfattyliverdiseaseapilotstudy
AT rodrigovalenzuela efficacyofsubmicrondispersiblefreephytosterolsonnonalcoholicfattyliverdiseaseapilotstudy